Abstract
Cancer stem cells are cellular subpopulations in tumor, which are highly tumorigenic and drug resistant due to their adaptive molecular mechanism. In the recent years, these cells have attracted researchers’ focus because of their unique properties which makes them biologically well evolved than other proliferating tumor cells. We have studied the presence of cancer stem cells in colorectal cancer (CRC) and its surgical margins. We report for the first time the presence of drug-resistant cells in distal resection margins in CRC and showed that a closer distal margin of less than 2 cm could have higher possibility of drug-resistant cells to spread.
Similar content being viewed by others
References
Ferlay J, Soerjomataram I, Ervik M, et al. (2013) GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide. Vol 11;. doi:http://globocan.iarc.fr/Default.aspx
Pal M (2004) Proportionate increase in incidence of colorectal cancer at an age below 40 years: an observation. J Cancer Res Ther 2(3):97–99
Bonadeo FA, Vaccaro CA, Benati ML, Quintana GM, Garione XE, Telenta MT (2001) Rectal cancer: local recurrence after surgery without radiotherapy. Dis Colon rectum 44(3):374–379
Wolpin BM, Mayer RJ (2008) Systemic treatment of colorectal cancer. Gastroenterology; 134(5).
Kozovska Z, Gabrisova V, Kucerova L. Colon cancer: cancer stem cells markers, drug resistance and treatment. doi:10.1016/j.biopha.2014.10.019.
Trédan O, Galmarini CM, Patel K, Tannock IF (2007) Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst 99(19):1441–1454
Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821–5828
Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730–737. doi:10.1038/nm0797-730
Singh S, Hawkins C, Clarke I, Squire J (2004) Identification of human brain tumour initiating cells. Nature 432:396–401. doi:10.1038/nature03031.1
Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA (2002) Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro. Glia 39(3):193–206
Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 100(7):3983–3988
O’Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106–110. doi:10.1038/nature05372
Li C, Heidt DG, Dalerba P et al (2007) Identification of pancreatic cancer stem cells. Cancer Res 67(3):1030–1037
Fang D, Nguyen TK, Leishear K et al (2005) A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 65(20):9328–9337
Prince ME, Sivanandan R, Kaczorowski A et al (2007) Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci 104(3):973–978. doi:10.1073/pnas.0610117104
Todaro M, Alea MP, Di Stefano AB et al (2007) Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1(4):389–402
Hlavata I, Mohelnikova-Duchonova B, Vaclavikova R et al (2012) The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis. doi:10.1093/mutage/ger075
Pawlik TM, Scoggins CR, Zorzi D et al (2005) Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 241:715–722 discussion 722-724
Espersen MLM, Olsen J, Linnemann D, Høgdall E, Troelsen JT (2015) Clinical implications of intestinal stem cell markers in colorectal cancer. Clin Colorectal Cancer 14(2):63–71
Bujko K, Rutkowski A, Chang GJ, Michalski W, Chmielik E, Kusnierz J (2011) Is the 1-cm rule of distal bowel resection margin in rectal cancer based on clinical evidence? A systematic review. Ann Surg Oncol. doi:10.1245/s10434-011-2035-2
Acknowledgements
This project was supported by research fellowship from Department of Biotechnology (DBT), Government of India. The authors thank Indu Ramachandran for assistance in flow cytometry, RGCB, Trivandrum, India.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
ᅟ
The study protocol conformed to the guidelines of the ethics committee of each institution and was approved by each institution’s review board; all patients provided written informed consent.
Conflict of Interest
The authors declare that they have no conflict of interest.
Funding
This work was supported by extra mural fund from Department of Biotechnology (DBT), Government of India. (BT/PR3223/BRB/10/964/2011).
Additional information
K. Chandramohan and Tapas Pradhan are joined first authors
Rights and permissions
About this article
Cite this article
Chandramohan, K., Pradhan, T. & Asha Nair, S. Identification and Quantification of Drug-Resistant Cells in Colorectal Tumor and Distal Margin. Indian J Surg Oncol 9, 141–145 (2018). https://doi.org/10.1007/s13193-017-0623-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-017-0623-8